Short-acting β2-agonist prescriptions in patients with asthma: findings from the South Korean cohort of SABINA III.

ABSTRACT:

Background/aims

Despite short-acting β2-agonist (SABA) overuse being associated with poor asthma outcomes, data on SABA use in South Korea is scarce. Herein, we describe prescription patterns of SABA and other asthma medications in patients from the South Korean cohort of the SABA use IN Asthma (SABINA) III study.

Methods

This study included patients with asthma aged ≥ 12 years, who had ≥ 3 consultations with the same healthcare provider, and medical records containing data for ≥ 12 months prior to the study visit. Patients were classified by investigator-defined asthma severity (per 2017 Global Initiative for Asthma recommendations) and practice type (primary or specialist care). Data on disease characteristics, asthma treatments, and clinical outcomes in the 12 months befo

SUBMITTER: Yoo KH 

PROVIDER: S-EPMC10790050 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature